1-3 of 3
Sven L. Klijn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Second-Line (2L) Treatment of Patients (pts) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL): Update with 34 Months of Liso-Cel Follow-up

Jeremy S. Abramson, Manali Kamdar, Fei Fei Liu, Alessandro Crotta, Alessandro Previtali, Sven L. Klijn, Pearl Wang, Yixie Zhang, Ashley Bonner, Matthew Lunning
Journal: Blood
Blood (2024) 144 (Supplement 1): 3130.
https://doi.org/10.1182/blood-2024-200937
Published: 2024
Journal Articles

Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes: Systematic Literature Review

Ralph V. Boccia, Sohan Deshpande, Caroline von Wilamowitz-Moellendorff, Renuka Raorane, Sven L. Klijn, Hong Xiao, Aylin Yucel
Journal: Blood
Blood (2022) 140 (Supplement 1): 12355–12356.
https://doi.org/10.1182/blood-2022-156783
Published: 2022
Journal Articles

Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (Liso-cel) Versus Axicabtagene Ciloleucel (Axi-cel) for Second-Line (2L) Treatment of Patients (Pt) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL)

Jeremy S. Abramson, Manali Kamdar, Fei Fei Liu, Alessandro Crotta, Alessandro Previtali, Sven L. Klijn, Pearl Wang, Aaron Situ, Yixie Zhang, Ashley Bonner, Matthew A. Lunning
Journal: Blood
Blood (2022) 140 (Supplement 1): 4655–4656.
https://doi.org/10.1182/blood-2022-160216
Published: 2022